Newsletter
Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

JAMA Editor’s Summary

Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

Editor's Audio Summary by Edward Livingston, MD, Deputy Editor, JAMA, the Journal of the American Medical Association, for the
August 16, 2016
ADVERTISEMENT

Newer →

Distinguishing bacterial from viral infection in young children, team-based care and health care quality, managing prescription drug costs, and more

← Older

Stroke prevention during TAVR, lipid screening in children and adolescents, clinical manifestations of CKD in diabetes, and more
Buffer LinkedIn WhatsApp

Abaloparatide for osteoporosis, cost-effectiveness of PCSK9 inhibitors, review of aortic dissection, and more

Editor’s Audio Summary by Edward Livingston, MD, Deputy Editor, JAMA, the Journal of the American Medical Association, for the August 16, 2016 issue

ADVERTISEMENT
ADVERTISEMENT
Support your Favorite Podcasts Leave a Review

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Silver Sponsors

Bronze Sponsors

Event and Media Partners

Buffer LinkedIn WhatsApp
00:00
00:00